Shannon Wiley Co-Authors Article on Building Compliance-Driven Infrastructure for Direct-to-Patient Programs

Bass, Berry & Sims attorney Shannon Wiley co-authored an article in Pharmaceutical Commerce examining the growing adoption of direct-to-patient (DTP) pharmaceutical programs and the complex compliance challenges that accompany their expansion. As manufacturers increasingly pursue DTP models to improve patient access and affordability, Shannon and her co-author Chander Viswanathan – chief technology, product and operations … Continued